FEDERICO, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 46.851
EU - Europa 26.006
AS - Asia 8.238
SA - Sud America 312
AF - Africa 163
OC - Oceania 134
Continente sconosciuto - Info sul continente non disponibili 39
Totale 81.743
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 46.477
GB - Regno Unito 9.688
IT - Italia 5.090
RU - Federazione Russa 2.633
SE - Svezia 2.406
CN - Cina 2.361
DE - Germania 2.066
SG - Singapore 2.008
UA - Ucraina 1.333
TR - Turchia 1.332
HK - Hong Kong 1.115
FI - Finlandia 752
FR - Francia 613
BG - Bulgaria 516
JP - Giappone 256
ID - Indonesia 255
VN - Vietnam 237
CA - Canada 221
BR - Brasile 205
IN - India 163
IE - Irlanda 160
NL - Olanda 141
BE - Belgio 123
KR - Corea 123
AU - Australia 122
BZ - Belize 107
ES - Italia 81
MY - Malesia 76
IR - Iran 70
CH - Svizzera 69
RO - Romania 69
EG - Egitto 44
TW - Taiwan 44
CZ - Repubblica Ceca 36
CL - Cile 35
LT - Lituania 32
MX - Messico 31
PL - Polonia 31
SA - Arabia Saudita 31
ZA - Sudafrica 30
EU - Europa 29
AT - Austria 25
NO - Norvegia 25
PK - Pakistan 23
TN - Tunisia 22
IL - Israele 21
AR - Argentina 20
CO - Colombia 19
IQ - Iraq 19
GR - Grecia 16
TH - Thailandia 16
BD - Bangladesh 15
MA - Marocco 15
AE - Emirati Arabi Uniti 12
DK - Danimarca 12
EE - Estonia 12
ET - Etiopia 12
HU - Ungheria 12
NZ - Nuova Zelanda 12
PE - Perù 11
PH - Filippine 10
PT - Portogallo 10
DZ - Algeria 9
HR - Croazia 9
RS - Serbia 9
EC - Ecuador 8
SI - Slovenia 8
A2 - ???statistics.table.value.countryCode.A2??? 7
MK - Macedonia 7
KE - Kenya 6
LU - Lussemburgo 6
LY - Libia 6
UZ - Uzbekistan 6
BO - Bolivia 5
JO - Giordania 5
KW - Kuwait 5
LK - Sri Lanka 5
PA - Panama 5
UG - Uganda 5
VE - Venezuela 5
AL - Albania 4
AZ - Azerbaigian 4
LV - Lettonia 4
AP - ???statistics.table.value.countryCode.AP??? 3
BY - Bielorussia 3
GE - Georgia 3
KG - Kirghizistan 3
LB - Libano 3
PR - Porto Rico 3
SC - Seychelles 3
AM - Armenia 2
AN - Antille olandesi 2
BH - Bahrain 2
CM - Camerun 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 81.719
Salva come PNG Salva come JPEG
Città #
Southend 8.518
Fairfield 6.425
Santa Clara 4.500
Ashburn 3.548
Woodbridge 3.548
Chandler 2.923
Houston 2.868
Jacksonville 2.627
Moscow 2.389
Seattle 2.385
Wilmington 2.209
Dearborn 2.112
Cambridge 2.071
Ann Arbor 1.635
Singapore 1.529
Nyköping 1.340
Hong Kong 1.044
Beijing 804
Izmir 776
San Diego 617
Princeton 589
Sofia 512
Frankfurt am Main 490
Eugene 476
Modena 458
Milan 328
Helsinki 309
Redwood City 308
New York 293
Des Moines 266
Jakarta 242
Rome 224
London 212
Dong Ket 206
San Jose 205
Shanghai 171
Bremen 168
Falls Church 143
Boardman 139
Dublin 139
Norwalk 108
Belize City 106
Bologna 97
Phoenix 88
Verona 83
Padova 77
Brussels 76
Hefei 75
Saint Petersburg 68
Nanjing 67
Tokyo 67
Philadelphia 66
Kunming 61
Las Vegas 61
Turin 59
Los Angeles 57
Munich 57
San Mateo 57
Albuquerque 56
Chicago 56
Toronto 56
Ottawa 55
Dallas 52
Paris 50
Guangzhou 47
Palermo 47
Florence 44
Naples 42
Kilburn 41
San Francisco 39
Saint Louis 38
Fremont 34
Chiswick 33
Bari 31
Hounslow 31
Seongnam 31
Columbus 30
Mountain View 30
Catania 29
Nanchang 29
Jinan 28
Istanbul 27
Parma 27
Tappahannock 26
Atlanta 25
Brno 25
Indiana 25
Seoul 25
Wuhan 25
Napoli 24
Torino 24
Leawood 23
São Paulo 23
Taipei 23
Ferrara 22
Manchester 22
San Giuliano Milanese 22
Washington 22
Genoa 21
Sydney 21
Totale 62.457
Salva come PNG Salva come JPEG
Nome #
SPLENECTOMY AFTER INITIAL THERAPY WITH ALPHA-IFN IN PATIENTS WITH HAIRY-CELL LEUKEMIA (HCL) - A MULTICENTER STUDY BY THE ITALIAN COOPERATIVE GROUP FOR HCL - PRELIMINARY-RESULTS 2.433
Hb Hasharon: studio di un nucleo familiare 1.193
Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12 1.066
Eritropoiesi extramidollare intratoracica. Considerazioni clinico radiologiche su due casi di talassemia minor 818
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 Trial 810
Cancer profile in Eastern Libya: incidence and mortality in the year 2004. 691
Cancer incidence in eastern Libya: The first report from the Benghazi Cancer Registry, 2003 659
Epidemiological overview of Hodgkin lymphoma across the Mediterranean Basin 658
Sindrome mediastinica da mieloblastoma quale manifestazione d'esordio di leucemia mieloide acuta 653
Estimates of cancer burden in Italy 619
Pattern of cancer risk in person with AIDS in Italy inthe HAART era 613
Risk assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas. 556
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial 538
Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma 530
IMPACT Working Group: effectiveness of service screening: a case-control study to assess breast cancer mortalità reduction. 528
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lmphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi 525
Caratterizzazione morfo-funzionale delle cellule reticolari dendritiche. 473
The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell Project 410
T-cell lymphoma in South America and Europe. 395
The italian multi-center project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk 391
Il morbo di Hodgkin sclero-nodulare. Studio clinico-patologico 383
Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study 338
Absolute monocyte count at diagnosis could improve the prognostic role of early FDG-PET in classical Hodgkin lymphoma patients 333
Il linfoma mantellare 332
Transformed follicular lymphoma 305
Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations 284
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program 273
Splenic marginal zone lymphoma: a prognostic model for clinical use. 268
Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study 264
Patologia non neoplastica del follicolo linfatico 256
Absolute monocyte count and lymphocyte-monocyte ratio predict outcome in nodular sclerosis Hodgkin lymphoma: Evaluation based on data from 1450 patients 253
Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. 249
Adapted treatment guided by interim PET-CT scan in advanced Hodgkin's lymphoma 249
Elongation factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility 249
A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive italian women 248
The outcome of peripheral t-cell lymphoma patients failing first-line therapy: A report from the prospective, international t-cell project 246
PET-CT for staging and early response: Results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study 244
Vinblastine, bleomycin, and methotrexate chemotherapy plus extended-field radiotherapy in early, favorably presenting, clinically staged Hodgkin's patients: The Gruppo Italiano per lo Studio dei Linfomi Experience 242
Defining the best cut-off value for lymphopenia in diffuse large B cell lymphoma treated with immuno-chemotherapy 241
Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network 239
Patogenesi complessa di una emopatia sistemica: la tricoleucemia 238
Collective evidence supports neutrality of BRCA1 V1687I, a novel sequence variant in the conserved THV motif of the first BRCT repeat 237
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications 237
Prophylactic Surgery to Reduce the Risk of Developing Breast Cancer: Issues and Clinical Implications 233
Italian family with two independent mutations:3358T/A in BRCA1 and 8756delA in BRCA2 genes. 232
Bleomycin, epidoxorubicin, cyclophosphamide, vincristine and prednisone (BACOP) in patients with follicular non-Hodgkin's lymphoma: Results of a prospective, multicenter study of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 231
KIT and PDGFRA mutations and the risk of GI stromal tumor recurrence 231
ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial. 230
Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi 230
Ovarian cancer: can proteomics give new insights for therapy and diagnosis? 230
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study 229
ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study. 228
Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study 226
Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas 225
Anthracyclines: a cornerstone in the management of non-Hodgkin's lymphoma. 223
Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphoma 221
EUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century 220
Nonpegylated liposomal doxorubicin (Myocet) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EURO 18 trial 220
The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL) 219
High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long-term results. 219
Follicular lymphoma international prognostic index. 219
Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-cell Lymphoma Project 217
Favourable ten-year overall survival in a Caucasian population with high probability of hereditary breast cancer. 217
Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience 216
Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy 216
Risk of second primary malignancy in breast cancer survivors: A nested population-based case-control study 216
Neutrophil-lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: Results of a large multicenter study involving 990 patients 216
Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal 213
Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis 212
Bone marrow uptake of liposome-entrapped spin label after liver blockade with empty liposomes 211
Age-adjusted international prognostic index is a predictor of survival in gastric diffuse B-cell non-Hodgkin lymphoma patients 211
Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma - The experience of the gruppo italiano studio linfomi 210
The length of treatment of aggressive non-Hodgkin's lymphomas established according to the international prognostic index score: long-term results of the GISL LA03 study 209
Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent years. 208
Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies 208
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study 206
Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study. 205
MRI in high risk women: benefits and problems 205
Interim PET-CT scan in advanced Hodgkin's lymphoma 205
Treatment of indolent B-cell nonfollicular lymphomas: Final results of the LL01 randomized trial of the Gruppo Italiano per lo Studio dei Linfomi 205
Follicular Lymphoma International Prognostic Index 2: a new prognostic index for follicular lymphoma developed by the International Follicular Lymphoma Prognostic Factor Project 204
Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies 204
A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias. 203
Tumor burden in Hodgkin's lymphoma can be reliably estimated from a few staging parameters. 203
Reply to T.P. Vassilakopoulos et al 203
Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma 202
Risk for second malignancies in non-Hodgkin's lymphoma survivors: a meta-analysis 200
Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: A systematic review and meta-analysis of randomized clinical trials 200
ESMO guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL) 199
Clinical categories identified by a new prognostic index reflect biological characteristics of patients in early chronic lymphocytic leukemia: The Gruppo Italiano Studio Linfomi (GISL) experience. 198
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis 198
Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: A population-based study 197
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia. 197
Protein expression patterns associated with advanced stage ovarian cancer 196
Dismal outcome of t-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer Registry 196
An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer 196
MRI before initial surgery outside of clinical trials: the real world! 195
Reply to H.J.A. Adams et al and E. Laffon et al 195
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature. 195
Cancer incidence, mortality, and survival in Eastern Libya: Updated report from the Benghazi Cancer Registry 194
Totale 32.814
Salva come PNG Salva come JPEG
Categoria #
all - tutte 306.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 306.130
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011.096 0 0 0 0 0 2.505 2.880 1.664 1.563 707 1.028 749
2020/202113.576 1.204 572 1.582 1.078 1.412 988 928 1.554 832 1.466 1.040 920
2021/202210.253 412 1.329 1.251 792 314 521 593 599 1.056 701 1.637 1.048
2022/20239.505 1.020 898 637 806 1.195 1.455 249 1.004 1.212 176 493 360
2023/20247.706 327 426 420 533 1.564 457 803 1.160 150 281 694 891
2024/20259.610 1.360 983 278 1.330 3.564 2.095 0 0 0 0 0 0
Totale 83.399